Clinical Trial Update: A Study to Investigate a Transdermal Continuous Glucose Monitoring System in Diabetic Patients for a Period of 28 Days [NA]

View source ↗

Summary

A clinical trial evaluating a transdermal continuous glucose monitoring system in diabetic patients for 28 days has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Transdermal Continuous Glucose Monitoring System

Snippet

Sponsor: EyeSense GmbH | Conditions: Diabetes (DM) | NA | Status: TERMINATED